SpicyIP Events: Pharma IPR India 2012, Mumbai, 31 Jan – 2 Feb 2012

For the Pharma enthusiasts amongst you, SpicyIP wishes to inform readers of the upcoming Pharma IPR India 2012, an event for managing IPR and driving global market entry strategy by analysing latest reforms, patentability and techno-legal intricacies in the pharma and biopharma industry.
The organisers of the event inform us that you will get an early bird discount upon registering with them before 9 December 2011. The organisers also send us the following details about the event:

DATES: 31 Jan: India Focus Day; 1 – 2 Feb: International Showcase Conference

VENUE: Holiday Inn Mumbai International Airport, Mumbai, India


CONTACT NUMBER: +91 (022) 4046 1466

EMAIL: [email protected]

URL: www.pharmaipr-india.com

You can also access details of this event from the SpicyIP Events calendar here (scroll to January 2012), and you can download and read the brochure here.

Against the backdrop of some very successful pharmaceutical events, CPhI brings to you the most demanded and detailed conference on pharmaceutical and biopharma intellectual property industry. Attend this unique conference for unveiling all your critical intellectual property related queries in the pharma and biopharma sectors and get on-the-spot solutions by leading global industry experts.

Don’t miss this one and only opportunity to take advantage of panel debates, interactive sessions, practical case studies and facilitated Q&A sessions.

This conference brings to you the latest updates and relevant in-depth information from India, USA, EU, Japan, Brazil and China on the most vital subjects including:

Highlight of the Conference

An opportunity to interact with the key decision makers, In-house counsels, Company Secretaries, Heads of Intellectual Property, Legal Affairs, Patents, Regulatory Affairs, R&D, International Business, Business Development, Sales and Marketing of leading pharmaceutical companies. Get practical experiences and advises from the leading domestic and international IPR experts, law firms and attorneys

Hear Cutting-Edge Case Studies From An Exceptional Line-Up Of Leading IPR Experts:

· Aaron F Barkoff, Partner, McAndrews, Held & Malloy, USA

· Gary J Speier, Senior Partner, Schwegman, Lundberg & Woessner, PA, USA

· Prabuddha Ganguli, CEO, Vision IPR, India

· Vijay Soni, Executive Vice President – IP, BD and Project Management, Glenmark Generics, USA

· Lorna Brazell, Partner, Bird & Bird, UK

· Alpesh Pathak, Head – API Patent Cell, Alembic Research Centre, Alembic Pharmaceuticals, India

· John P Iwanicki, Senior Partner, Banner & Witcoff, USA

· Hari Subramaniam, Principal, Subramaniam, Nataraj & Associates, India

· Mandar Kodgule, Associate Vice President and Head, Global Intellectual Property and Strategic Planning, Wockhardt, India

· Rana Gosain, Daniel Advogados, Brazil

· Gabriel Di Blasi, Partner, Di Blasi, Parente & Associados, Brazil

· Swati Veera, Senior In-House Patent, Attorney and Head – Patents, Piramal Life Sciences, India

· Gopakumar G Nair, Hon Chairman, GNAnLeX Hermeneutics, India

· Koen Bijvank, Partner Vereenigde, Netherlands

· Sailesh K Patel, Partner, Schiff Hardin, USA

· Komal Shah Bukhanwala Director, InnovarIP, India

· Jeffrey S Ward, Partner, Merchant & Gould PC, USA

· Gautam Bakshi, Head and Assistant General Manager – Intellectual Property, Promed Research Centre, India

· Sujatha Subramaniam, Consultant, F Hoffmann La Roche, Switzerland and Managing Partner, IdeeIP Consultant, India

· Aaron D Hurvitz, Foreign Counsel, Kangxin Partners PC, China

· D Christopher Ohly, Partner, Schiff Hardin, USA

· Kazuaki Tasaka, Patent Attorney, Nagasawa Patent Firm / The Tokyo-Marunouchi Law Offices, Japan

· Pravin Anand, Managing Partner, Anand and Anand, India

Quote “SpicyIP-Dec” and benefit from early bird discounts! For further information, please contact Ms Asan Bano on +91 (022) 4046 1466, email [email protected] or visit www.pharmaipr-india.com .

Tags: ,

About The Author

Leave a Reply

Scroll to Top